Showing results (171-180 of 215) with videos related to
Sort By:
Pageof 22
The Journal of Steroid Biochemistry and Molecular Biology|July 25, 2023
Genetic variants in the vitamin D pathway and their association with vitamin D metabolite levels: Detailed studies of an inner-city pediatric population suggest a modest but significant effect in early childhoodLei Fu, Betty Y L Wong, Zhenyu Li, et al.The Journal of Steroid Biochemistry and Molecular Biology|March 20, 2010
Sun exposure questionnaire predicts circulating 25-hydroxyvitamin D concentrations in Caucasian hospital workers in southern ItalyH E C Hanwell, R Vieth, D E C Cole, et al.Epidemiology (Cambridge, Mass.)|May 3, 2007
Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified populationJoel G Ray, Philip R Wyatt, Miles D Thompson, et al.The Journal of Clinical Endocrinology and Metabolism|May 25, 2006
Diagnosis of parathyroid tumors in familial isolated hyperparathyroidism with HRPT2 mutation: implications for cancer surveillanceVito Guarnieri, Alfredo Scillitani, Lucia Anna Muscarella, et al.Molecular Diagnosis & Therapy|December 13, 2006
G-protein-coupled receptors and asthma endophenotypes: the cysteinyl leukotriene system in perspectiveMiles D Thompson, Jun Takasaki, Valérie Capra, et al.Breast Cancer Research and Treatment|September 5, 2009
A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancerO C Freedman, E Amir, W Hanna, et al.Clinical Biochemistry|February 27, 2007
Genetic variation at the calcium-sensing receptor (CASR) locus: implications for clinical molecular diagnosticsFrancisco H J Yun, Betty Y L Wong, Maretta Chase, et al.The Journal of Clinical Endocrinology and Metabolism|May 21, 2015
Cinacalcet Treatment in an Adolescent With Concurrent 22q11.2 Deletion Syndrome and Familial Hypocalciuric Hypercalcemia Type 3 Caused by AP2S1 MutationSirpa Tenhola, Geoffrey N Hendy, Helena Valta, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 27, 2006
Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapyMark J Clemons, George Dranitsaris, Wei S Ooi, et al.The Journal of Clinical Endocrinology and Metabolism|March 13, 2002
Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemiaLilia D'Souza-Li, Bing Yang, Lucie Canaff, et al.Pageof 22